Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
BOLD Boundless Bio
- 2.460
- -0.490-16.61%
Close Dec 13 16:00 ET
- 2.470
- +0.010+0.41%
Post 20:01 ET
54.86MMarket Cap-0.90P/E (TTM)
2.840High2.460Low193.45KVolume2.840Open2.950Pre Close491.13KTurnover1.36%Turnover RatioLossP/E (Static)22.30MShares15.24052wk High0.33P/B34.91MFloat Cap2.33052wk Low--Dividend TTM14.19MShs Float15.240Historical High--Div YieldTTM12.88%Amplitude2.330Historical Low2.538Avg Price1Lot Size
About Boundless Bio Company
Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in San Diego, CA.
Company Profile
SymbolBOLD
Company NameBoundless Bio
Listing DateMar 28, 2024
Issue Price16.00
Founded2018
CEOMr. Zachary D. Hornby
MarketNASDAQ
Employees72
Fiscal Year Ends12-31
Address9880 Campus Point Drive,Suite 120
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-766-9912
Websitehttp://www.boundlessbio.com
Company Executives
- Name
- Position
- Salary
- Zachary D. Hornby
- President, Chief Executive Officer and Director
- 2.37M
- Neil Abdollahian
- Chief Business Officer
- --
- Dr. Klaus W. Wagner, M.D.,PhD
- Chief Medical Officer
- 996.66K
- Christian Hassig, PhD
- Chief Business Officer
- 903.51K
- Jessica Oien
- Chief Legal Officer and Corporate Secretary
- --
- David A. Hinkle
- Treasurer, Principal Financial Officer and Principal Accounting Officer
- --
- Dr. Jonathan E. Lim,M.D.
- Chairman of the Board
- 61.17K
- Kristina M. Burow
- Independent Director
- --
- Dr. Fabio Pucci, PhD
- Independent Director
- --
- Dr. James Christensen, PhD
- Independent Director
- 102.74K
- Dr. Jakob Loven, PhD
- Independent Director
- --
- Jennifer Lew
- Independent Director
- 66.55K
- Dr. Christine Brennan, PhD
- Independent Director
- --
- Dr. Nancy C. Whiting, Pharm.D.
- Independent Director
- 102.74K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.